Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
April
(30)
- Inspirational Patient Perspective with NFL Legend ...
- Welcome to The Second and Final Day of the Conference
- Virtual Pharma: Addressing Challenges and Opportun...
- Understanding the Concepts of Disruptive Innovatio...
- Creating a Competitive Advantage through Sourcing
- Approaches to Address the Impact of Increasingly C...
- Clinical Trials: What Does Global Mean to You?
- MMAX: Development, Evolution, Growth and Maturatio...
- Leading Through Change: Innovation and the Future ...
- Wall Street’s 2009 Forecast and Analysis of Outsou...
- Live from the 18th Annual Partnerships with CROs
- Driving Global Growth: Strategic Considerations f...
- Governance and Supplier Relationship Management
- FierceBiotech is the Official Digital Media and Li...
- Speaker Profile: Peter B. Corr
- Speaker Profile: Harris Koffer, Pharm.D
- Speaker Profile: Christopher C. Gallen, MD, PhD
- Clinical trial begins for a malaria vaccine
- The Use of Bid Grids for Selecting a CRO as a Partner
- Partnerships with CROs April LinkedIn Update: Merg...
- Full Details are Required for Indian Clinical Trials
- Join us: Global Congress on Comparator Studies
- Partnerships with CROs & Other Outsourcing Provide...
- Patient recruitment costs continue to increase in ...
- Key Findings on CRO Industry
- France focuses on Clinical Trials
- CardioNet Expands into CRO Industry by Acquring Bi...
- The Political Economy of Pharmaceutical Clinical T...
- ICON teaming up with MedAvante
- New CenterWatch Report Examines Japan’s Surging Cl...
-
▼
April
(30)
No comments:
Post a Comment